France

France

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.38 (1.30 - 1.44) 2019 Modelled IHME
1.4 (1.33 - 1.46) 2018 Modelled IHME
1.42 (1.35 - 1.48) 2017 Modelled IHME
1.43 (1.36 - 1.49) 2016 Modelled IHME
1.44 (1.36 - 1.50) 2015 Modelled IHME
1.45 (1.37 - 1.51) 2014 Modelled IHME
1.47 (1.40 - 1.53) 2013 Modelled IHME
1.49 (1.42 - 1.55) 2012 Modelled IHME
1.51 (1.44 - 1.57) 2011 Modelled IHME
1.52 (1.45 - 1.59) 2010 Modelled IHME
1.54 (1.46 - 1.60) 2009 Modelled IHME
1.55 (1.47 - 1.61) 2008 Modelled IHME
1.56 (1.48 - 1.63) 2007 Modelled IHME
1.57 (1.49 - 1.64) 2006 Modelled IHME
1.59 (1.50 - 1.66) 2005 Modelled IHME
1.6 (1.51 - 1.67) 2004 Modelled IHME
1.61 (1.52 - 1.68) 2003 Modelled IHME
1.62 (1.53 - 1.69) 2002 Modelled IHME
1.63 (1.54 - 1.70) 2001 Modelled IHME
1.65 (1.55 - 1.72) 2000 Modelled IHME
1.66 (1.57 - 1.73) 1999 Modelled IHME
1.66 (1.58 - 1.74) 1998 Modelled IHME
1.67 (1.59 - 1.74) 1997 Modelled IHME
1.68 (1.60 - 1.75) 1996 Modelled IHME
1.69 (1.60 - 1.76) 1995 Modelled IHME
1.7 (1.62 - 1.77) 1994 Modelled IHME
1.71 (1.63 - 1.78) 1993 Modelled IHME
1.72 (1.64 - 1.79) 1992 Modelled IHME
1.73 (1.65 - 1.81) 1991 Modelled IHME
1.75 (1.65 - 1.83) 1990 Modelled IHME
0.8 (0.70 - 0.90) 2010 Survey/reported Ramiere, 2016
0.7 (0.50 - 0.90) 2004 Survey/reported Meffre C , 2010
0.02 (0.02 - 0.03) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.07 (0.05 - 0.09) 2019 Modelled IHME
0.07 (0.06 - 0.09) 2018 Modelled IHME
0.08 (0.06 - 0.10) 2017 Modelled IHME
0.09 (0.07 - 0.11) 2016 Modelled IHME
0.1 (0.08 - 0.12) 2015 Modelled IHME
0.12 (0.09 - 0.14) 2014 Modelled IHME
0.14 (0.11 - 0.17) 2013 Modelled IHME
0.16 (0.13 - 0.20) 2012 Modelled IHME
0.19 (0.15 - 0.24) 2011 Modelled IHME
0.22 (0.17 - 0.27) 2010 Modelled IHME
0.24 (0.19 - 0.30) 2009 Modelled IHME
0.28 (0.22 - 0.34) 2008 Modelled IHME
0.31 (0.24 - 0.38) 2007 Modelled IHME
0.33 (0.26 - 0.42) 2006 Modelled IHME
0.36 (0.27 - 0.45) 2005 Modelled IHME
0.37 (0.29 - 0.47) 2004 Modelled IHME
0.39 (0.30 - 0.49) 2003 Modelled IHME
0.4 (0.32 - 0.51) 2002 Modelled IHME
0.42 (0.32 - 0.53) 2001 Modelled IHME
0.43 (0.33 - 0.55) 2000 Modelled IHME
0.44 (0.34 - 0.56) 1999 Modelled IHME
0.45 (0.36 - 0.56) 1998 Modelled IHME
0.46 (0.37 - 0.57) 1997 Modelled IHME
0.48 (0.37 - 0.59) 1996 Modelled IHME
0.49 (0.38 - 0.60) 1995 Modelled IHME
0.51 (0.41 - 0.62) 1994 Modelled IHME
0.54 (0.43 - 0.65) 1993 Modelled IHME
0.56 (0.45 - 0.68) 1992 Modelled IHME
0.59 (0.47 - 0.72) 1991 Modelled IHME
0.62 (0.49 - 0.77) 1990 Modelled IHME
0.01 (0.01 - 0.01) 2015 Modelled WHO
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.4 (0.70 - 2.40) 2009 Survey/reported Sauvage C et al , 2015
Pregnant women
Download
Value (%) Year Type Source
0.8 (0.60 - 0.70) 2011 Survey/reported Richaud-Eyraud E et al, 2015
Prisoners
Download
Value (%) Year Type Source
0.6 (0.10 - 2.10) 2013 Survey/reported Corinne B et al, 2015.

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.64 (1.98 - 3.41) 2019 Modelled IHME
2.68 (2.03 - 3.47) 2018 Modelled IHME
2.74 (2.08 - 3.52) 2017 Modelled IHME
2.76 (2.10 - 3.55) 2016 Modelled IHME
2.86 (2.20 - 3.67) 2015 Modelled IHME
2.84 (2.19 - 3.64) 2014 Modelled IHME
2.91 (2.26 - 3.73) 2013 Modelled IHME
2.97 (2.30 - 3.80) 2012 Modelled IHME
3.01 (2.34 - 3.83) 2011 Modelled IHME
3.06 (2.37 - 3.90) 2010 Modelled IHME
3.09 (2.39 - 3.90) 2009 Modelled IHME
3.1 (2.40 - 3.92) 2008 Modelled IHME
3.12 (2.41 - 3.94) 2007 Modelled IHME
3.16 (2.44 - 4.01) 2006 Modelled IHME
3.22 (2.48 - 4.08) 2005 Modelled IHME
3.28 (2.53 - 4.16) 2004 Modelled IHME
3.46 (2.65 - 4.38) 2003 Modelled IHME
3.54 (2.71 - 4.49) 2002 Modelled IHME
3.6 (2.76 - 4.57) 2001 Modelled IHME
3.65 (2.80 - 4.63) 2000 Modelled IHME
3.72 (2.87 - 4.74) 1999 Modelled IHME
3.73 (2.88 - 4.76) 1998 Modelled IHME
3.68 (2.84 - 4.70) 1997 Modelled IHME
3.67 (2.83 - 4.62) 1996 Modelled IHME
3.62 (2.80 - 4.56) 1995 Modelled IHME
3.58 (2.75 - 4.54) 1994 Modelled IHME
3.54 (2.72 - 4.51) 1993 Modelled IHME
3.5 (2.68 - 4.50) 1992 Modelled IHME
3.5 (2.66 - 4.52) 1991 Modelled IHME
3.52 (2.66 - 4.54) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,750 (1,314 - 2,259) 2019 Modelled IHME
1,770 (1,341 - 2,288) 2018 Modelled IHME
1,802 (1,371 - 2,316) 2017 Modelled IHME
1,808 (1,377 - 2,331) 2016 Modelled IHME
1,867 (1,435 - 2,401) 2015 Modelled IHME
1,850 (1,428 - 2,367) 2014 Modelled IHME
1,886 (1,460 - 2,413) 2013 Modelled IHME
1,916 (1,482 - 2,446) 2012 Modelled IHME
1,932 (1,499 - 2,458) 2011 Modelled IHME
1,952 (1,512 - 2,488) 2010 Modelled IHME
1,959 (1,516 - 2,476) 2009 Modelled IHME
1,959 (1,518 - 2,476) 2008 Modelled IHME
1,956 (1,513 - 2,474) 2007 Modelled IHME
1,969 (1,521 - 2,500) 2006 Modelled IHME
1,993 (1,534 - 2,527) 2005 Modelled IHME
2,016 (1,559 - 2,557) 2004 Modelled IHME
2,112 (1,622 - 2,679) 2003 Modelled IHME
2,150 (1,646 - 2,724) 2002 Modelled IHME
2,174 (1,667 - 2,756) 2001 Modelled IHME
2,186 (1,677 - 2,775) 2000 Modelled IHME
2,219 (1,711 - 2,827) 1999 Modelled IHME
2,215 (1,710 - 2,821) 1998 Modelled IHME
2,171 (1,677 - 2,778) 1997 Modelled IHME
2,158 (1,665 - 2,719) 1996 Modelled IHME
2,125 (1,643 - 2,677) 1995 Modelled IHME
2,093 (1,608 - 2,655) 1994 Modelled IHME
2,067 (1,589 - 2,632) 1993 Modelled IHME
2,035 (1,556 - 2,619) 1992 Modelled IHME
2,029 (1,544 - 2,624) 1991 Modelled IHME
2,031 (1,536 - 2,625) 1990 Modelled IHME
3,845 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
12 (8 - 17) 2019 Modelled IHME
12 (8 - 17) 2018 Modelled IHME
12 (8 - 17) 2017 Modelled IHME
12 (8 - 17) 2016 Modelled IHME
12 (8 - 17) 2015 Modelled IHME
12 (8 - 17) 2014 Modelled IHME
12 (8 - 17) 2013 Modelled IHME
12 (8 - 17) 2012 Modelled IHME
12 (8 - 17) 2011 Modelled IHME
12 (8 - 17) 2010 Modelled IHME
12 (8 - 17) 2009 Modelled IHME
12 (9 - 17) 2008 Modelled IHME
12 (9 - 17) 2007 Modelled IHME
12 (9 - 18) 2006 Modelled IHME
12 (9 - 18) 2005 Modelled IHME
12 (9 - 18) 2004 Modelled IHME
12 (9 - 18) 2003 Modelled IHME
12 (9 - 18) 2002 Modelled IHME
13 (9 - 18) 2001 Modelled IHME
13 (9 - 18) 2000 Modelled IHME
13 (9 - 18) 1999 Modelled IHME
13 (9 - 18) 1998 Modelled IHME
13 (9 - 18) 1997 Modelled IHME
13 (9 - 18) 1996 Modelled IHME
13 (9 - 19) 1995 Modelled IHME
13 (9 - 19) 1994 Modelled IHME
13 (9 - 19) 1993 Modelled IHME
13 (9 - 19) 1992 Modelled IHME
13 (9 - 19) 1991 Modelled IHME
13 (9 - 19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
90 2018 Survey/reported WHO/UNICEF
90 2017 Survey/reported WHO/UNICEF
90 2016 Survey/reported WHO/UNICEF
88 2015 Survey/reported WHO/UNICEF
83 2014 Survey/reported WHO/UNICEF
82 2013 Survey/reported WHO/UNICEF
78 2012 Survey/reported WHO/UNICEF
74 2011 Survey/reported WHO/UNICEF
64 2010 Survey/reported WHO/UNICEF
51 2009 Survey/reported WHO/UNICEF
47 2008 Survey/reported WHO/UNICEF
42 2007 Survey/reported WHO/UNICEF
39 2006 Survey/reported WHO/UNICEF
35 2005 Survey/reported WHO/UNICEF
35 2004 Survey/reported WHO/UNICEF
28 2003 Survey/reported WHO/UNICEF
29 2002 Survey/reported WHO/UNICEF
28 2001 Survey/reported WHO/UNICEF
26 2000 Survey/reported WHO/UNICEF
24 1999 Survey/reported WHO/UNICEF
27 1998 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
109 2015 Survey/reported EMCDDA, 2019
150 (127 - 186) 2014 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
85 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.85 (0.70 - 1.04) 2019 Modelled IHME
0.85 (0.69 - 1.03) 2018 Modelled IHME
0.84 (0.69 - 1.03) 2017 Modelled IHME
0.84 (0.69 - 1.02) 2016 Modelled IHME
0.84 (0.68 - 1.03) 2015 Modelled IHME
0.84 (0.68 - 1.03) 2014 Modelled IHME
0.84 (0.68 - 1.03) 2013 Modelled IHME
0.84 (0.69 - 1.03) 2012 Modelled IHME
0.84 (0.69 - 1.03) 2011 Modelled IHME
0.84 (0.69 - 1.04) 2010 Modelled IHME
0.83 (0.68 - 1.01) 2009 Modelled IHME
0.8 (0.65 - 0.96) 2008 Modelled IHME
0.75 (0.62 - 0.90) 2007 Modelled IHME
0.71 (0.59 - 0.85) 2006 Modelled IHME
0.69 (0.57 - 0.83) 2005 Modelled IHME
0.68 (0.57 - 0.82) 2004 Modelled IHME
0.67 (0.56 - 0.81) 2003 Modelled IHME
0.67 (0.56 - 0.80) 2002 Modelled IHME
0.66 (0.55 - 0.80) 2001 Modelled IHME
0.66 (0.55 - 0.80) 2000 Modelled IHME
0.67 (0.56 - 0.81) 1999 Modelled IHME
0.68 (0.57 - 0.83) 1998 Modelled IHME
0.7 (0.58 - 0.86) 1997 Modelled IHME
0.72 (0.59 - 0.88) 1996 Modelled IHME
0.74 (0.60 - 0.89) 1995 Modelled IHME
0.74 (0.61 - 0.90) 1994 Modelled IHME
0.75 (0.62 - 0.90) 1993 Modelled IHME
0.75 (0.62 - 0.91) 1992 Modelled IHME
0.75 (0.62 - 0.91) 1991 Modelled IHME
0.76 (0.62 - 0.92) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1 (0.90 - 1.20) 2010 Survey/reported Ramiere, 2016
0.84 (0.65 - 1.10) 2004 Survey/reported Meffre C et al, 2010
0.6 (0.40 - 1.10) 2014 Modelled Gower et al, 2014
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1 (0.50 - 1.90) 2009 Survey/reported Sauvage C et al , 2015
People who inject drugs (PWID)
Download
Value (%) Year Type Source
62.2 (59.40 - 64.90) 2011 Survey/reported Weill-Barillet L et al, 2016
Prisoners
Download
Value (%) Year Type Source
6.3 (6.10 - 6.50) 2016 Modelled ECDC

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
8.09 (6.60 - 9.63) 2019 Modelled IHME
8.11 (6.62 - 9.64) 2018 Modelled IHME
8.15 (6.63 - 9.73) 2017 Modelled IHME
8.06 (6.56 - 9.60) 2016 Modelled IHME
8.17 (6.60 - 9.74) 2015 Modelled IHME
8.04 (6.51 - 9.53) 2014 Modelled IHME
8.12 (6.66 - 9.64) 2013 Modelled IHME
8.16 (6.68 - 9.77) 2012 Modelled IHME
8.14 (6.65 - 9.77) 2011 Modelled IHME
8.11 (6.62 - 9.74) 2010 Modelled IHME
8.03 (6.57 - 9.68) 2009 Modelled IHME
7.93 (6.47 - 9.58) 2008 Modelled IHME
7.79 (6.40 - 9.41) 2007 Modelled IHME
7.72 (6.33 - 9.35) 2006 Modelled IHME
7.71 (6.29 - 9.34) 2005 Modelled IHME
7.68 (6.28 - 9.31) 2004 Modelled IHME
7.86 (6.50 - 9.54) 2003 Modelled IHME
7.85 (6.44 - 9.54) 2002 Modelled IHME
7.82 (6.40 - 9.52) 2001 Modelled IHME
7.83 (6.40 - 9.50) 2000 Modelled IHME
7.97 (6.52 - 9.69) 1999 Modelled IHME
7.92 (6.45 - 9.69) 1998 Modelled IHME
7.75 (6.28 - 9.49) 1997 Modelled IHME
7.66 (6.18 - 9.36) 1996 Modelled IHME
7.48 (6.02 - 9.11) 1995 Modelled IHME
7.31 (5.88 - 8.87) 1994 Modelled IHME
7.11 (5.73 - 8.65) 1993 Modelled IHME
6.92 (5.58 - 8.46) 1992 Modelled IHME
6.82 (5.50 - 8.38) 1991 Modelled IHME
6.75 (5.42 - 8.34) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
5,356 (4,369 - 6,375) 2019 Modelled IHME
5,353 (4,373 - 6,365) 2018 Modelled IHME
5,367 (4,363 - 6,406) 2017 Modelled IHME
5,287 (4,304 - 6,294) 2016 Modelled IHME
5,340 (4,315 - 6,367) 2015 Modelled IHME
5,228 (4,237 - 6,199) 2014 Modelled IHME
5,260 (4,314 - 6,244) 2013 Modelled IHME
5,261 (4,306 - 6,293) 2012 Modelled IHME
5,221 (4,261 - 6,265) 2011 Modelled IHME
5,175 (4,225 - 6,216) 2010 Modelled IHME
5,096 (4,168 - 6,144) 2009 Modelled IHME
5,008 (4,087 - 6,051) 2008 Modelled IHME
4,890 (4,019 - 5,906) 2007 Modelled IHME
4,814 (3,950 - 5,833) 2006 Modelled IHME
4,777 (3,895 - 5,783) 2005 Modelled IHME
4,726 (3,865 - 5,731) 2004 Modelled IHME
4,804 (3,972 - 5,830) 2003 Modelled IHME
4,764 (3,910 - 5,790) 2002 Modelled IHME
4,715 (3,861 - 5,741) 2001 Modelled IHME
4,692 (3,835 - 5,696) 2000 Modelled IHME
4,748 (3,883 - 5,773) 1999 Modelled IHME
4,695 (3,828 - 5,749) 1998 Modelled IHME
4,580 (3,711 - 5,604) 1997 Modelled IHME
4,506 (3,636 - 5,506) 1996 Modelled IHME
4,385 (3,528 - 5,343) 1995 Modelled IHME
4,275 (3,440 - 5,189) 1994 Modelled IHME
4,147 (3,340 - 5,045) 1993 Modelled IHME
4,026 (3,246 - 4,923) 1992 Modelled IHME
3,954 (3,188 - 4,857) 1991 Modelled IHME
3,901 (3,132 - 4,820) 1990 Modelled IHME
4,917 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
45 (35 - 55) 2019 Modelled IHME
46 (36 - 55) 2018 Modelled IHME
46 (36 - 56) 2017 Modelled IHME
46 (36 - 55) 2016 Modelled IHME
46 (36 - 56) 2015 Modelled IHME
46 (36 - 55) 2014 Modelled IHME
45 (36 - 55) 2013 Modelled IHME
45 (36 - 55) 2012 Modelled IHME
45 (36 - 55) 2011 Modelled IHME
45 (35 - 55) 2010 Modelled IHME
45 (35 - 55) 2009 Modelled IHME
45 (35 - 55) 2008 Modelled IHME
44 (34 - 54) 2007 Modelled IHME
44 (34 - 54) 2006 Modelled IHME
44 (33 - 54) 2005 Modelled IHME
43 (33 - 54) 2004 Modelled IHME
43 (33 - 53) 2003 Modelled IHME
43 (32 - 53) 2002 Modelled IHME
42 (32 - 53) 2001 Modelled IHME
42 (32 - 53) 2000 Modelled IHME
42 (32 - 52) 1999 Modelled IHME
42 (32 - 52) 1998 Modelled IHME
42 (32 - 52) 1997 Modelled IHME
42 (31 - 52) 1996 Modelled IHME
42 (31 - 52) 1995 Modelled IHME
41 (31 - 52) 1994 Modelled IHME
41 (31 - 52) 1993 Modelled IHME
41 (31 - 51) 1992 Modelled IHME
40 (31 - 51) 1991 Modelled IHME
40 (30 - 51) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 2015 Survey/reported EMCDDA, 2019
150 (127 - 186) 2014 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
85 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
1.38 (%)
2019
(1.3 - 1.44(%))
IHME
HCV (RNA/cAg+)
0.85 (%)
2019
(0.7 - 1.04(%))
IHME

Survey/surveillance

HBV (HBsAg+)
0.8 (%)
2010
(0.7 - 0.9(%))
Ramiere, 2016
HCV (anti-HCV)
1 (%)
2010
(0.9 - 1.2(%))
Ramiere, 2016

Hepatitis related deaths (national)

Modelled

HBV
1,750
2019
(1,314 - 2,259)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
5,356
2019
(4,369 - 6,375)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.07 (%)
2019, latest modelled
(0.05 - 0.09(%))
IHME

Prevalence PWID

HCV
62.20 (%)
2011, survey/surveillance
(59.40 - 64.90(%))
Weill-Barillet L et al, 2016

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
109
2015
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources